Dexamethasone for preterm infants at risk of bronchopulmonary dysplasia: is timing everything?

Eur Respir J. 2023 Oct 19;62(4):2301473. doi: 10.1183/13993003.01473-2023. Print 2023 Oct.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bronchopulmonary Dysplasia*
  • Dexamethasone / therapeutic use
  • Glucocorticoids / therapeutic use
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Propensity Score

Substances

  • Glucocorticoids
  • Dexamethasone